News

There are many benefits for sites adopting electronic informed consent and it is vital that site study teams are not bystanders in the move towards its use.

To encourage experimentation with more complex clinical trial strategies, FDA plans to launch a pilot program to assess complex studies proposed by sponsors.

Updated employee announcements, business news, awards, and recognition in the industry today.

Education Falsification has more consequences than not having a degree.

This article will analyze industry clinical trial initiatives and investigate strategies on how to improve impact on people.

The clinical trials industry craves blockchain technology to provide data safety and authenticity.

Biomarker and specialty lab data are increasingly being incorporated in FDA submissions given the robust insights they provide on key clinical objectives, including pharmacological effects, and drug safety and effectiveness.

Relocating the European Medicines Agency was always going to be hard-but no-one ever expected it to degenerate into farce.

With technology’s increasing ability to gather and analyze previously unmanageable data sets, and medicine’s forays into genomics and targeted therapies, the time of the master protocol may be at hand.

With Open Payments it is possible for Pfizer to better understand its own investigator usage pattern and how that pattern may differ from the practices of other pharmaceutical companies.